Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Champlin

Showing results (161-170 of 218) with videos related to

Pageof 22
Sort By:
Transplantation and Cellular Therapy|August 22, 2023
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell LymphomaHanan Alkhaldi, Alec Reinhardt, Melissa Barnett, et al.
Cancer|August 27, 2015
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaFarhad Ravandi, Susan M O'Brien, Jorge E Cortes, et al.
Transplantation and Cellular Therapy|March 30, 2021
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host DiseaseRohtesh S Mehta, Rima M Saliba, Anna Jan, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2015
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory LymphomasYago Nieto, Benigno C Valdez, Peter F Thall, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
British Journal of Haematology|September 4, 2018
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinibPreetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2014
Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemiaNaveen Pemmaraju, Dhaval Shah, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
JAMA Oncology|September 1, 2017
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical TrialElias Jabbour, Farhad Ravandi, Partow Kebriaei, et al.
Pageof 22

Showing results (161-170 of 218) with videos related to

Sort By:
Pageof 22
Transplantation and Cellular Therapy|August 22, 2023
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell LymphomaHanan Alkhaldi, Alec Reinhardt, Melissa Barnett, et al.
Cancer|August 27, 2015
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaFarhad Ravandi, Susan M O'Brien, Jorge E Cortes, et al.
Transplantation and Cellular Therapy|March 30, 2021
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host DiseaseRohtesh S Mehta, Rima M Saliba, Anna Jan, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2015
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory LymphomasYago Nieto, Benigno C Valdez, Peter F Thall, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
British Journal of Haematology|September 4, 2018
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinibPreetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2014
Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemiaNaveen Pemmaraju, Dhaval Shah, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
JAMA Oncology|September 1, 2017
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical TrialElias Jabbour, Farhad Ravandi, Partow Kebriaei, et al.
Pageof 22